DLHCX | JFNIX | DLHCX / JFNIX | |
Total Expense Ratio | 1.96 | 0.77 | 255% |
Annual Report Gross Expense Ratio | 2.00 | 0.77 | 260% |
Fund Existence | 16 years | 16 years | - |
Gain YTD | 3.908 | 1.338 | 292% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 636M | 4.49B | 14% |
Annual Yield % from dividends | 0.00 | 0.39 | - |
Returns for 1 year | -17.02 | -14.01 | 121% |
Returns for 3 years | -1.45 | 18.71 | -8% |
Returns for 5 years | -14.58 | 6.41 | -227% |
Returns for 10 years | 23.35 | 38.20 | 61% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TIBRX | 31.77 | 0.16 | +0.51% |
Thornburg Investment Income Builder R3 | |||
RLUEX | 12.53 | N/A | N/A |
Lazard US Equity Concentrated R6 | |||
FBDIX | 141.31 | N/A | N/A |
Franklin Biotechnology Discovery A | |||
CFSIX | 21.70 | N/A | N/A |
Touchstone Sands Capital Select Growth Y | |||
BIRDX | 8.49 | N/A | N/A |
iShares Developed Real Estate Idx Instl |